Dr Reddy's Laboratories, has launched Zoledronic Acid Injection (4mg/5ml), a bioequivalent generic version of Zometa (zoledronic acid) 4 mg/5ml injection in the US market on March 4, 2012, following the approval by the United States Food & Drug Administration (USFDA) of the company's ANDA for Zoledronic acid injection (4 mg/5ml). The company’s Zoledronic Acid Injection 4mg/5ml is available in a single use vial of concentrate.
Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1893.60 |
| Dr. Reddys Labs. | 1412.00 |
| Cipla | 1486.00 |
| Zydus Lifesciences | 1118.00 |
| Lupin | 2397.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: